Lonza Group AG (SWX: LONN) Stock Analysis & Fundamentals | ScreenerHero

Create free account

LONNLonza Group AG

SWX · CH · Healthcare · Diagnostics & Research · lonza.com

545.80CHF+2.10%Mkt Cap: 43.51B $P/E: 41.981d ago

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/E

Pricier

P/B

Avg

Div Yield

Higher

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap43.51B $

Enterprise Value48.09B $

Revenue (TTM)7.45B $

Gross Profit2.64B $

Net Income (TTM)-313.86M $

Revenue/Share106.45 USD

Last Price545.80 CHF

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees20.0K

CountryCH

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)41.98

P/E (Forward)25.01

PEG1.57

EV/EBITDA19.72

EV/Revenue6.45

P/S5.84

P/B4.82

EPS (TTM)13.00

EPS (Forward)21.82

52W Range

454.6065% of range594.80

52W High594.80 CHF

52W Low454.60 CHF

Profitability

Gross Margin35.35%

Oper. Margin21.39%

EBITDA Margin32.72%

Profit Margin-4.21%

ROE-3.48%

ROA-1.54%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF1.32B $

CapEx (TTM)1.57B $

FCF Margin-27.54%

FCF Yield-4.72%

Net Debt4.52B $

Net Debt/EBITDA1.85

Balance Sheet

Debt/Equity0.57

Current Ratio1.89

Quick Ratio0.62

Book Value/Sh113.30 CHF

Cash/Share10.29 CHF

Dividends

Fwd Div Rate5.000 CHF

Trail. Div Rate5.000 CHF

Div. Yield0.93%

5Y Avg Yield0.67%

Payout Ratio30.77%

Ex-Div DateMay 12, 2026

Pay DateMay 15, 2025

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)665.48 CHF

Upside (mean)+21.9%

Target Range550.00 CHF – 815.00 CHF

CHF550.00+21.9% to meanCHF815.00

# Analysts23

Ownership

Shares Out.69.84M

Float69.81M

Insiders0.09%

Institutions61.38%

Technical

SMA 50494.61 (+10.4%)

SMA 200521.97 (+4.6%)

Beta0.83

S&P 52W Chg20.05%

Avg Vol (30d)150.22K

Avg Vol (10d)173.35K

Technical Indicators

RSI (14)76.2

MACD10.9488

MACD Signal5.4017

MACD Hist.+5.5471

BB Upper539.86 CHF

BB Middle503.14 CHF

BB Lower466.42 CHF

BB Width14.60%

ATR (14)12.29 CHF

Vol Ratio (20d)1.05x